These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 25288266)

  • 1. Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen.
    Spanakis N; Tsiodras S; Haagmans BL; Raj VS; Pontikis K; Koutsoukou A; Koulouris NG; Osterhaus AD; Koopmans MP; Tsakris A
    Int J Antimicrob Agents; 2014 Dec; 44(6):528-32. PubMed ID: 25288266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination therapy with lopinavir/ritonavir, ribavirin and interferon-α for Middle East respiratory syndrome.
    Kim UJ; Won EJ; Kee SJ; Jung SI; Jang HC
    Antivir Ther; 2016; 21(5):455-9. PubMed ID: 26492219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-β1b (MIRACLE trial): study protocol for a randomized controlled trial.
    Arabi YM; Alothman A; Balkhy HH; Al-Dawood A; AlJohani S; Al Harbi S; Kojan S; Al Jeraisy M; Deeb AM; Assiri AM; Al-Hameed F; AlSaedi A; Mandourah Y; Almekhlafi GA; Sherbeeni NM; Elzein FE; Memon J; Taha Y; Almotairi A; Maghrabi KA; Qushmaq I; Al Bshabshe A; Kharaba A; Shalhoub S; Jose J; Fowler RA; Hayden FG; Hussein MA;
    Trials; 2018 Jan; 19(1):81. PubMed ID: 29382391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical and virological features of the first imported case causing MERS-CoV outbreak in South Korea, 2015.
    Lee JY; Kim YJ; Chung EH; Kim DW; Jeong I; Kim Y; Yun MR; Kim SS; Kim G; Joh JS
    BMC Infect Dis; 2017 Jul; 17(1):498. PubMed ID: 28709419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Systematic Review of therapeutic agents for the treatment of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV).
    Momattin H; Al-Ali AY; Al-Tawfiq JA
    Travel Med Infect Dis; 2019; 30():9-18. PubMed ID: 31252170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Middle East respiratory syndrome with a combination of lopinavir/ritonavir and interferon-β1b (MIRACLE trial): statistical analysis plan for a recursive two-stage group sequential randomized controlled trial.
    Arabi YM; Asiri AY; Assiri AM; Aziz Jokhdar HA; Alothman A; Balkhy HH; AlJohani S; Al Harbi S; Kojan S; Al Jeraisy M; Deeb AM; Memish ZA; Ghazal S; Al Faraj S; Al-Hameed F; AlSaedi A; Mandourah Y; Al Mekhlafi GA; Sherbeeni NM; Elzein FE; Almotairi A; Al Bshabshe A; Kharaba A; Jose J; Al Harthy A; Al Sulaiman M; Mady A; Fowler RA; Hayden FG; Al-Dawood A; Abdelzaher M; Bajhmom W; Hussein MA;
    Trials; 2020 Jan; 21(1):8. PubMed ID: 31900204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lopinavir/ritonavir for the treatment of SARS, MERS and COVID-19: a systematic review.
    Vargas M; Servillo G; Einav S
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8592-8605. PubMed ID: 32894567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study.
    Omrani AS; Saad MM; Baig K; Bahloul A; Abdul-Matin M; Alaidaroos AY; Almakhlafi GA; Albarrak MM; Memish ZA; Albarrak AM
    Lancet Infect Dis; 2014 Nov; 14(11):1090-1095. PubMed ID: 25278221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Middle Eastern Respiratory Syndrome Corona Virus (MERS CoV): case reports from a tertiary care hospital in Saudi Arabia.
    Khalid M; Khan B; Al Rabiah F; Alismaili R; Saleemi S; Rehan-Khaliq AM; Weheba I; Al Abdely H; Halim M; Nadri QJ; Al Dalaan AM; Zeitouni M; Butt T; Al Mutairy E
    Ann Saudi Med; 2014; 34(5):396-400. PubMed ID: 25827696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV.
    Sheahan TP; Sims AC; Leist SR; Schäfer A; Won J; Brown AJ; Montgomery SA; Hogg A; Babusis D; Clarke MO; Spahn JE; Bauer L; Sellers S; Porter D; Feng JY; Cihlar T; Jordan R; Denison MR; Baric RS
    Nat Commun; 2020 Jan; 11(1):222. PubMed ID: 31924756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study.
    Al-Tawfiq JA; Momattin H; Dib J; Memish ZA
    Int J Infect Dis; 2014 Mar; 20():42-6. PubMed ID: 24406736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ribavirin and interferon-α2b as primary and preventive treatment for Middle East respiratory syndrome coronavirus: a preliminary report of two cases.
    Khalid M; Al Rabiah F; Khan B; Al Mobeireek A; Butt TS; Al Mutairy E
    Antivir Ther; 2015; 20(1):87-91. PubMed ID: 24831606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical analysis of the first patient with imported Middle East respiratory syndrome in China].
    Ling Y; Qu R; Luo Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Aug; 27(8):630-4. PubMed ID: 26255008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MERS-CoV: Understanding the Latest Human Coronavirus Threat.
    Chafekar A; Fielding BC
    Viruses; 2018 Feb; 10(2):. PubMed ID: 29495250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on therapeutic options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV).
    Al-Tawfiq JA; Memish ZA
    Expert Rev Anti Infect Ther; 2017 Mar; 15(3):269-275. PubMed ID: 27937060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treating MERS-CoV during an outbreak.
    Coleman CM; Frieman MB
    Lancet Infect Dis; 2014 Nov; 14(11):1030-1031. PubMed ID: 25278219
    [No Abstract]   [Full Text] [Related]  

  • 17. Laboratory investigation and phylogenetic analysis of an imported Middle East respiratory syndrome coronavirus case in Greece.
    Kossyvakis A; Tao Y; Lu X; Pogka V; Tsiodras S; Emmanouil M; Mentis AF; Tong S; Erdman DD; Antoniadis A
    PLoS One; 2015; 10(4):e0125809. PubMed ID: 25919137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of candidate therapies for Middle East respiratory syndrome from a molecular perspective.
    Rabaan AA; Alahmed SH; Bazzi AM; Alhani HM
    J Med Microbiol; 2017 Sep; 66(9):1261-1274. PubMed ID: 28855003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset.
    Chan JF; Yao Y; Yeung ML; Deng W; Bao L; Jia L; Li F; Xiao C; Gao H; Yu P; Cai JP; Chu H; Zhou J; Chen H; Qin C; Yuen KY
    J Infect Dis; 2015 Dec; 212(12):1904-13. PubMed ID: 26198719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-sectional study of MERS-CoV-specific RNA and antibodies in animals that have had contact with MERS patients in Saudi Arabia.
    Kasem S; Qasim I; Al-Hufofi A; Hashim O; Alkarar A; Abu-Obeida A; Gaafer A; Elfadil A; Zaki A; Al-Romaihi A; Babekr N; El-Harby N; Hussien R; Al-Sahaf A; Al-Doweriej A; Bayoumi F; Poon LLM; Chu DKW; Peiris M; Perera RAPM
    J Infect Public Health; 2018; 11(3):331-338. PubMed ID: 28993171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.